CMC welcomes the recent announcement from the MHRA relating to CBMPs

The Centre for Medicinal Cannabis welcomes the recent announcement from the Medicines and Healthcare products Regulatory Agency (MHRA) regarding the process for approving manufacturing authorisations or API registrations of Cannabis Based Medicinal Products (CBMPs). The piece outlines the MHRA and Home Office licensing requirements for companies and facilities operating within the UK, and provides clarity …